路新利

个人简介

路新利，博士，主任技师，硕士研究生导师。毕业于河北大学。先后入选河北省“三三三人才工程”第二层次人选和石家庄市市管拔尖人才。现任河北省疾病预防控制中心性病艾滋病防治所副所长(主持工作)。主要从事艾滋病性病丙肝防治工作。

研究方向：新发感染、分子流行病学与耐药研究

研究成果：先后主持承担河北省自然科学基金（面上）等省市级项目多项。在JID、Front Micro、BMC Infect Dis、Arch Virol、AIDS Res Ther、Sci Rep等国内外权威杂志发表学术论文100余篇，其中SCI收录论文40余篇。获河北省科技进步奖一等奖1项（第2名）、河北省科技进步奖二等奖1项、河北医学科技奖一等奖多项。担任河北省病毒学会副会长、河北省医学会医学生化分会候任主任委员、中国艾滋病协会检测促进委员会和性病专委会委员、河北省微生物学会理事、河北省检验检疫学会理事等学术职务。

主要代表性论文：

1. Lu X,et al. Epidemic trend, genetic characteristics, and transmission networks of HIV-1 among treatment-naive men who have sex with men in Hebei province, China.Front Microbiol. 2024;15:1405565.

2. Lu X(corresponding author), et al.Identification of a new HIV-1 circulating recombinant form (CRF159_01103) derived from CRF103_01B and CRF01_AE in Hebei Province, China. Sci Rep. 2024;14(1):13182.

3. Lu X, et al. Changes of Viral Load, Drug Resistance, and CD4 Cell Count in HIV-1-Infected Patients Receiving Antiretroviral Therapy in Hebei Province, China, 2003-2019. AIDS Res Hum Retroviruses. 2023 39(10):558-566.

4. Lu X,et al. Recombinant characteristics of three novel HIV-1 second-generation recombinant forms composed of CRF01_AE and CRF07_BC isolated in Hebei province, China. Arch Virol. 2023;168(4):111.

5. Lu X(corresponding author), et al. Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China. Front Genet. 2022; 13:975397.

6. Lu X, et al. Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022. Front. Cell. Infect. Microbiol. 2025; 15:1510916.